← FDA Drug Approvals (Drugs@FDA)

TOBRAMYCIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2019-04-19

Drug application

FDA Application #

ANDA211847

Application type

Abbreviated New Drug Application (Generic)

Brand name

TOBRAMYCIN

Generic name

TOBRAMYCIN OPHTHALMIC SOLUTION

Active ingredients

TOBRAMYCIN

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

ALEMBIC

Manufacturer

Alembic Pharmaceuticals Inc.

First approval

2019-04-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown